Light Protection When Young, Strong Coverage in Old Age... Kyobo Life Launches ‘Kyobo My Plan Health Insurance II’

Kyobo Life Insurance announced on the 2nd that it has launched the 'Kyobo My Plan Health Insurance II (non-participating)'.

First introduced last year, 'Kyobo My Plan Health Insurance' is a comprehensive health insurance product that allows policyholders to select only the riders they need based on their health status and financial situation. The newly released revised product maintains the previous flexible design system, while focusing on reducing the premium burden for people in their 30s and 40s and addressing coverage gaps for the elderly.

The company has introduced two new riders: '80 Plus 100 (Extended Maturity Rider for Three Major Diseases)' and '80 Up 100 (Step-Up Rider for Three Major Diseases),' both of which cover cancer, cerebrovascular diseases, and ischemic heart diseases. The '80 Plus 100' rider allows policyholders to sign up for coverage for the three major diseases with maturity at age 80, making premiums more affordable during their economically active years. If certain conditions are met at age 80, coverage can be extended to age 100, thus filling potential coverage gaps in advanced age. The '80 Up 100' rider provides 50% of the insured amount until age 80 to lower premium payments, then doubles the coverage to 100% after age 80, thereby helping to address increased medical expenses in retirement.

Coverage for treatment options reflecting current medical trends has also been enhanced. The policy broadly covers high-cost, severe disease treatments such as specific targeted radiation therapy, advanced cancer carbon ion radiation therapy, non-reimbursed cancer treatments, cancer robotic surgery, inpatient treatment in stroke intensive care units, key treatments for cerebrovascular and heart disease, thrombolytic therapy, and major treatments and hospitalizations at tertiary general hospitals.

In addition, new coverage features have been added, including the 'Specific Circulatory System Disease Injection Therapy Rider,' which covers anticoagulant and antiplatelet injection treatments, as well as the 'Specific Circulatory System Disease Oral Medication Therapy Rider,' which covers warfarin and next-generation oral anticoagulant (NOAC) medication. These enhancements improve competitiveness by expanding protection throughout the treatment process.

With a total of 198 optional riders, customers can design a finely tailored plan suited to their health status, family history, and financial circumstances. The product also offers a no-cash-surrender-value structure, which keeps premiums lower than standard plans, and extends the rider renewal cycle for up to 20 years, while also providing a variety of non-renewable riders.

A Kyobo Life Insurance spokesperson stated, "'Kyobo My Plan Health Insurance' has long been a flagship product, beloved for its customer-driven design flexibility and unique riders. With this revision, we expect to further lower insurance costs for people in their 30s and 40s and enhance coverage for the elderly and access to the latest treatments, strengthening our position as a reliable lifelong health partner for customers."

This content was produced with the assistance of AI translation services.